BIOSTAR PHARM-B(02563): Expected audit reservation opinion

13:18 25/03/2026

Huahao Zhongtian Pharmaceuticals-B (02563) issued an announcement, the board of directors of the company hereby notifies the shareholders and potential investors that, during the audit of the comprehensive financial statements for the year ended December 31, 2025, the company's auditor indicated that they are expected to issue a qualified opinion in the audit report.

BIOSTAR PHARM-B (02563) Announces that during the review of the comprehensive financial statements for the year ended December 31, 2025, the company's auditors have indicated that they expect to issue a qualified opinion in their audit report. The company's board of directors hereby informs its shareholders and potential investors of this matter.

HK Stock Market Move | KINETIC DEV (01277) rose more than 11% after the performance report, planning to distribute a final dividend of 6 Hong Kong cents per share. Institutions pointed out that the company has outstanding high dividend characteristics.

HK Stock Market Move | Zejing Holdings (02632) regained its IPO price on the second day of listing, with a surge of over 70% at one point during the trading session.

Morgan Stanley: China Telecom Corporation (00728) underperformed expectations in the fourth quarter of last year with a target price of 5.5 Hong Kong dollars.

HK Stock Market Move | Zejing Holdings (02632) regained its IPO price on the second day of listing, with a surge of over 70% at one point during the trading session.

Morgan Stanley: China Telecom Corporation (00728) underperformed expectations in the fourth quarter of last year with a target price of 5.5 Hong Kong dollars.